G protein-activated K+ channels (Kir3 or GIRK) are activated by direct binding of Gbetagamma. The binding sites of Gbetagamma in the ubiquitous GIRK1 (Kir3.1) subunit have not been unequivocally charted, and in the neuronal GIRK2 (Kir3.2) subunit the binding of Gbetagamma has not been studied. We verified and extended the map of Gbetagamma-binding sites in GIRK1 by using two approaches: direct binding of Gbetagamma to fragments of GIRK subunits (pull down), and competition of these fragments with the Galphai1 subunit for binding to Gbetagamma. We also mapped the Gbetagamma-binding sites in GIRK2. In both subunits, the N terminus binds Gbetagamma. In the C terminus, the Gbetagamma-binding sites in the two subunits are not identical; GIRK1, but not GIRK2, has a previously unrecognized Gbetagamma-interacting segments in the first half of the C terminus. The main C-terminal Gbetagamma-binding segment found in both subunits is located approximately between amino acids 320 and 409 (by GIRK1 count). Mutation of C-terminal leucines 262 or 333 in GIRK1, recognized previously as crucial for Gbetagamma regulation of the channel, and of the corresponding leucines 273 and 344 in GIRK2 dramatically altered the properties of K+ currents via GIRK1/GIRK2 channels expressed in Xenopus oocytes but did not appreciably reduce the binding of Gbetagamma to the corresponding fusion proteins, indicating that these residues are mainly important for the regulation of Gbetagamma-induced changes in channel gating rather than Gbetagamma binding.

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M304518200DOI Listing

Publication Analysis

Top Keywords

binding gbetagamma
20
gbetagamma-binding sites
16
gbetagamma
9
sites girk1
8
girk1 girk2
8
girk2 subunits
8
direct binding
8
gbetagamma binding
8
subunit binding
8
binding
7

Similar Publications

Developing Topics.

Alzheimers Dement

December 2024

INIMEC-CONICET-UNC, Cordoba, Argentina.

Background: Aβ accumulation is a key event driving neurotoxicity in Alzheimer's disease. Previously, we demonstrated that oligomers of amyloid beta (oAβ) induce an increase in the levels of APP and BACE1 in Rab11-positive endosomes, leading to the intracellular accumulation of Aβ1-42 in human neurons derived from iPSCs (HN-iPSCs). This vicious cycle of Aβ generation induced by Aβ itself, is pivotal for the propagation of pathology.

View Article and Find Full Text PDF

The G protein inhibitor YM-254890 is an allosteric glue.

bioRxiv

November 2024

Department of Biochemistry, Biophysics, and Chemical Biology, University of Pennsylvania, Philadelphia, PA, 19104-6059.

Article Synopsis
  • G protein coupled receptors (GPCRs) are vital drug targets, and targeting their downstream G proteins might offer new therapeutic options, as demonstrated by the compound YM-254890 that inhibits specific Gq/11 activity in uveal melanoma.
  • Despite the promise, research into other specific G protein inhibitors has struggled, indicating a need to better understand YM’s mechanism of action.
  • The study reveals that specific Gα proteins favored by YM have unique conformations, and there’s strong allosteric interaction between YM and Gβγ, suggesting that YM enhances the stability of the G protein complex, promoting its effectiveness.
View Article and Find Full Text PDF

Gallein is a known Gβγ subunit inhibitor, but its function in bone metabolism, especially in osteoblasts, and its molecular mechanism remains to be elucidated. Osteoprotegerin (OPG), which is secreted from osteoblasts, binds to nuclear factor kB receptor activator (RANK) ligand (RANKL) as a decoy receptor, prevents RANKL-RANK binding, and inhibits bone resorption. IL-6 is not only a bone resorption factor but also as a bone metabolism regulator.

View Article and Find Full Text PDF

The inflammatory mediator prostaglandin E (PGE) binds to G-coupled EP2 and EP4 receptors. These receptors are located in the locus coeruleus (LC), the principal noradrenergic nucleus in the brain, but their functional role remains unknown. In this study, the PGE EP2 and EP4 receptors in LC cells from male rat brain slices were pharmacologically characterized by single-unit extracellular electrophysiology.

View Article and Find Full Text PDF
Article Synopsis
  • Cell death is crucial for maintaining balance in living organisms, and abnormal FPR1 expression in keratinocytes can lead to a harmful cell death process called necroptosis, which disrupts skin barrier function.
  • This study focused on understanding how FPR1 activation triggers cell death in keratinocytes using HaCaT cells, while assessing various signaling pathways involved.
  • Results showed that stimulating purinergic receptor P2X7 increases FPR1 levels and activates cell death through the Gβγ-pERK signaling pathway, suggesting that targeting these pathways could offer new treatment options to prevent damaging cell death in the skin.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!